Company profile
Epiminder
Continuous insights. Life uninterrupted.
- Industry
- Biotechnology Research
- Employees
- 41
- Headquarters
- Melbourne
- Founded
- 2017
- Office locations
- 2
Epiminder company summary
Epiminder is a company in the Biotechnology Research industry, headquartered in Melbourne, founded in 2017. On LinkedIn the company has around 41 employees. The company lists 2 office locations. Its listed specialties include neurotechnology and neurology.
What technology does Epiminder use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Epiminder
Epilepsy is a complex neurological condition affecting over 50 million people globally, with a significant part of the patient population not responding to traditional medication. Epilepsy not only imposes chronic, debilitating effects but also subjects patients to the unpredictable nature of when and how seizures might occur. Epiminder Limited is revolutionising epilepsy care with its implantable continuous EEG monitoring (iCEM®) system, the Minder® system. Minder has been granted authorization via the FDA's de novo pathway and is building a commercial presence in the US. Seizure diaries are often unreliable, the true picture of a patient's condition may be different from what it initially appears. This creates gaps in understanding of what treatments should be deployed to address the patient’s underlying condition. The Minder system will address this gap by unveiling continuous and objective EEG data that would not otherwise been seen. Like other diagnostic devices used in conditions requiring continuous monitoring of physiological signals (e.g. implantable cardiac monitors and continuous glucose monitors), the Minder system represents a significant leap forward in epilepsy care, providing objective insights that enable informed clinical actions. Headquartered in Melbourne, Australia, with an office in Dallas, TX, USA, Epiminder is a public company dedicated to advancing neurological health.
Specialties
Where is Epiminder located?
Epiminder lists 2 office locations.
Compare companies similar to Epiminder
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Epiminder epiminder.com | Biotechnology Research | 41 | 2017 | Melbourne |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Epiminder
What does Epiminder do?
Epilepsy is a complex neurological condition affecting over 50 million people globally, with a significant part of the patient population not responding to traditional medication. Epilepsy not only imposes chronic, debilitating effects but also subjects patients to the unpredictable nature of when and how seizures might occur. Epiminder Limited is revolutionising epilepsy care with its implantable continuous EEG monitoring (iCEM®) system, the Minder® system. Minder has been granted authorization via the FDA's de novo pathway and is building a commercial presence in the US. Seizure diaries are often unreliable, the true picture of a patient's condition may be different from what it initially appears. This creates gaps in understanding of what treatments should be deployed to address the patient’s underlying condition. The Minder system will address this gap by unveiling continuous and objective EEG data that would not otherwise been seen. Like other diagnostic devices used in conditions requiring continuous monitoring of physiological signals (e.g. implantable cardiac monitors and continuous glucose monitors), the Minder system represents a significant leap forward in epilepsy care, providing objective insights that enable informed clinical actions. Headquartered in Melbourne, Australia, with an office in Dallas, TX, USA, Epiminder is a public company dedicated to advancing neurological health.
How many employees does Epiminder have?
Epiminder has around 41 employees on LinkedIn.
Where is Epiminder headquartered?
Epiminder is headquartered in Melbourne.
Where does Epiminder have offices?
Epiminder lists 2 office locations, including Melbourne, AU, AU; Dallas, US, US.
When was Epiminder founded?
Epiminder was founded in 2017.
Build a lead list from companies like Epiminder
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.